Taro's Keveyis 50 mg Tablets Available for Treatment of Primary Hyperkalemic, Hypokalemic Periodic Paralysis
September 21, 2015 at 13:35 PM EDT
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that Keveyis™ (dichlorphenamide) 50 mg Tablets, the first ...